CLINICAL ROLE -
Cosentyx Shows Promise Treating Nail, Palmoplantar Psoriasis
Patients with moderate-to-severe nail psoriasis treated with secukinumab experienced significant improvement in the Nail Psoriasis Severity Index.
Read More
Opioid Abuse Risk Highest Among Baby Boomers, Millennials
Baby boomers found to have a relatively high rate of drug abuse compared with other generations.
Opioid Withdrawal Treatment Gets Priority Review
Lofexidine treats symptoms associated with opioid withdrawal and supports discontinuation of opioids.
Approval Sought for Plaque Psoriasis Drug
New Drug Applications filed for halobetasol propionate and tazarotene lotion, a topical treatment for plaque psoriasis.
Fingolimod Effective Against Multiple Sclerosis Relapse in Pediatric Patients
Fingolimod shows 82% efficacy reducing the annualized multiple sclerosis relapse rate.
Endometriosis Pain Drug Gets FDA Priority Review
Elagolix is an orally administered gonadotropin-releasing hormone or GnRH antagonist for endometriosis with associated pain.
Single Tablet HIV Regimen Shows Promise
Once-daily HIV treatment found to be highly effective and well-tolerated in treating antiretroviral-naïve HIV-1 patients.
Bipolar Drug Begins Phase 3 Clinical Trials
Trials will evaluate the efficacy of brexpiprazole in patients with bipolar I disorder who experience an acute manic episode, with or without mixed features, requiring hospitalization.
Phase 3 Trial for Psoriasis Vulgaris Drug Enrolls First Patient
Calcipotriene and betamethasone dipropionate treats mild to moderate plaque psoriasis in adult patients.
FDA Rejects Treatment for Low Testosterone in Hypogonadism
QuickShot Testosterone (Xyosted) application rejected due to deficiencies related to clinical data.
Stelara Approved to Treat Plaque Psoriasis in Adolescents
Ustekinumab (Stelara) treats moderate to severe plaque psoriasis in adolescents who are candidates for phototherapy or systemic therapy.
Alzheimer's Disease Drug Falls Short in Phase 3 Trial
The novel drug, intepirdine, was under investigation to treat patients with mild to moderate Alzheimer’s disease who were receiving donepezil therapy.